NASDAQ
Cyclerion Therapeutics, Inc. (CYCN) has a free cash flow growth of 21.34% as of Friday, May 29, 2026. This represents a 111.07% increase compared to its 12-month average of -192.86%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.